Professor Theresa A McDonagh
Professor of Heart Failure and Consultant Cardiologist
King’s College Hospital
Denmark Hill
London, SE5 9RS
Tel:020 3299 4475
Email: theresa.mcdonagh@kcl.ac.uk
Qualifications
- University of Edinburgh Medical School (1981-87), BSc (Hons)1985, MBChB (Hons)1987, MD 1999
- MRCP UK 1990
- CCT in Cardiology Nov 1997
Biography
I completed my general medical training in Edinburgh. I was then a Research Fellow in Cardiology at the Western Infirmary in Glasgow from 1991-1994 and a Lecturer at the CRI in Heart Failure, University of Glasgow (Honorary Senior Registrar) from 1994-1999. Working on the epidemiology of Left Ventricular Dysfunction and Natriuretic Peptides with Professor Henry J Dargie.
Subsequently I was appointed as a Senior Lecturer (Honorary Consultant Cardiologist) at the University of Glasgow and Glasgow Royal Infirmary where I ran the Heart Failure Service and was the Cardiologist involved in the Heart Transplant Programme (199-2004). I was appointed as a Consultant Cardiologist with an Interest in Heart Failure at the Royal Brompton Hospital, London (2004-2011) before moving to King's College Hospital as a Consultant Cardiologist and Professor of Heart Failure.
Research interests
My research interests are in clinical heart failure in particular the epidemiology of heart failure and left ventricular dysfunction and the role of biomarkers.
My early research focused on BNP in heart failure. I am now interested in more novel biomarkers and have recently supervised research involving apelin and ST2.In addition I have an interest in the delivery of heart failure care.
Group members
Membership of Societies
- British Society for Heart Failure (Board member since 2001, Chair 2009-2011)
- Heart Failure Association of ESC (Board member 2010 onwards)
- British Cardiovascular Society.
- Current Committee member for ESC Guidelines, ESC Programme and ESC Education Committees.
- Current Chair of ESC HFA Patient Care Committee
- Clinical Lead for the National Heart Failure Audit
- Former member of SAC in Cardiology (2004-2010).
Books edited
- Oxford Specialist Handbook of Heart failure
Authors/Editors: RS Gardner, TA McDonagh, NL Walker
Oxford University Press
ISBN-13: 978-0-19-920573-8
- Oxford Textbooks in Cardiology: Heart Failure
McDonagh TA, Gardner RG, Clark AL, Dargie HJ
In Press July 2012.Oxford University Press
Selected publications
- Mantziari L, Guha K, Khalique Z, McDonagh T, Sharma R. Relation of dosing of the Renin-Angiotensin system inhibitors after cardiac resynchronization therapy to long-term prognosis. Am J Cardiol. 2012 Jun 1;109(11):1619-25.
- Alpendurada F, Guha K, Sharma R, Ismail TF, Clifford A, Banya W, Mohiaddin RH, Pennell DJ, Cowie MR, McDonagh T, Prasad SK. Right ventricular dysfunction is a predictor of non-response and clinical outcome following cardiac resynchronization therapy. J Cardiovasc Magn Reson. 2011 Oct 31;13:68.
- Cleland JG, McDonagh T, Rigby AS, Yassin A, Whittaker T, Dargie HJ; National Heart Failure Audit Team for England and Wales. The national heart failure audit for England and Wales 2008-2009. Heart. 2011 Jun;97(11):876-86.
- Chandrasekaran B, Kalra PR, Donovan J, Hooper J, Clague JR, McDonagh TA..Myocardial Apelin Production is Reduced in Humans with Left Ventricular Systolic Dysfunction. J Card Fail. 2010 (7):556-61.
- Cleland JG, McDonagh T, Dargie HJ; on behalf of the National Heart Failure Audit Team for England and Wales. The nationalheart failure audit for England and Wales 2008-2009. Heart. 2010 Dec 20.
- McDonagh TA, Blue L, Clark AL, et al. on behalf of Heart Failure Association Committee on Patient Care. European Society of Cardiology Heart Failure Association Standards for delivering heart failure care. Eur J Heart Fail. 2011;13(3):235-241.
- Weir R, McDonagh TA, Chong V, McMurray JJ, Dargie HJ. Plasma apelin concentration is depressed following acute myocardial infarction in man, European Journal of Heart Failure. 2009:;11(6):551-8.
- Gardner RS, Chong KS, O'Meara E, Jardine A, Ford I, McDonagh TA. Renal dysfunction, as measured by the modification of diet in renal disease equations, and outcome in patients with advanced heart failure. Eur Heart J. 2007.
- Chong KS, Gardner RS, Morton JJ, Ashley EA, McDonagh TA. Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure.Eur J Heart Fail. 2006 Feb 3
- Gardner RS, Chong V, Morton I, McDonagh TA.N-terminal brain natriuretic peptide is a more powerful predictor of mortality than endothelin-1, adrenomedullin and tumour necrosis factor-alpha in patients referred for consideration of cardiac transplantation. Eur J Heart Fail. 2005 Mar 2;7(2):253-60.
- Gardner RS, Ozalp F, Murday AJ, Robb SD, McDonagh TA.N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J. 2003 Oct;24(19):1735-43.
- McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE,Tunstall-Pedoe H, McMurray JJ, Dargie HJ. Biochemical detection of left-ventricular systolic dysfunction. Lancet. 1998 Jan 3;351(9095):9-13.
- McDonagh TA, Morrison CE, Lawrence A, Ford I, Tunstall-Pedoe H, McMurray JJ, Dargie HJ. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population.Lancet. 1997 Sep 20;350(9081):829-33.